ADNOCDRILL earnings per share for the last quarter are 0.08 AED whereas the estimation was 0.06 AED which accounts for 20.91% surprise. Företagets omsättning för samma period uppgår till 3.09 B AED trots den uppskattade siffran 3.03 B AED. Estimated earnings per share for the next quarter are 0.07 AED, and revenue is expected to reach 3.24 B AED. Also watch annual changes over time to get a bigger picture of ADNOCDRILL earnings per share and revenue dynamics.